Naylor Stuart — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Naylor Stuart has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $668K.

Profile

Stuart Naylor is listed as Chief Development Officer of MeiraGTx Holdings plc, a clinical-stage gene therapy company, based on SEC filing information with CIK 0001742771 as of 2026-01-09. The filing indicates he holds the Chief Development Officer role, with no reported purchases or sales in that filing.

Board memberships

• MeiraGTx Holdings plc

Awards & honors

• Led development strategy for MeiraGTx's gene therapy pipeline
• Oversaw clinical development programs targeting ocular, CNS, and salivary gland disorders
• Contributed to regulatory strategy and translational development of AAV-based therapies

Recent Transactions

Companies — Last 90 Days

• MeiraGTx Holdings plc (MGTX) — 2 filings, last 2026-07-08

Frequently Asked Questions

Who is Naylor Stuart?

Stuart Naylor is listed as Chief Development Officer of MeiraGTx Holdings plc, a clinical-stage gene therapy company, based on SEC filing information with CIK 0001742771 as of 2026-01-09. The filing indicates he holds the Chief Development Officer role, with no reported purchases or sales in that filing.…

How many SEC Form 4 filings has Naylor Stuart submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Naylor Stuart been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 3 open-market sales ($668K) across all tracked filings.

Where can I see all of Naylor Stuart's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week